Go Pro
LON:MANO

Manolete Partners (MANO) Share Price, News & Analysis

Manolete Partners logo
GBX 36.15 -1.85 (-4.87%)
As of 09/18/2026 11:34 AM Eastern

About Manolete Partners Stock (LON:MANO)

Advanced

Key Stats

Today's Range
36.15
40
50-Day Range
35
44
52-Week Range
32
100
Volume
21,702 shs
Average Volume
72,393 shs
Market Capitalization
£15.90 million
P/E Ratio
14.70
Dividend Yield
0.37%
Price Target
GBX 67
Consensus Rating
Buy

Company Overview

Manolete Partners Plc is the UK's leading insolvency claims financing company. Serving a growing market worth over £500 million annually, the Company has a highly experienced team with coverage across the UK and a proven track record of generating strong historic returns across over 1,300 cases financed and completed to date. Widely recognised as the industry leader, Manolete is the only company in the insolvency litigation funding section to be ranked in Band 1 of the legal industry's prestigious Chambers Guide five times. The Company is also five-time winner of 'Insolvency Litigation Funder of the Year' at the Turnaround, Restructuring and Insolvency Industry Awards.

Receive MANO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Manolete Partners and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MANO Stock News Headlines

The hidden costs of a hands-off retirement account
Contributing to your 401(k) consistently is good financial behavior - but contributing and optimizing are two different things. High fees, heavy company stock concentration, and target-date funds that follow a formula rather than your situation can quietly erode your balance over time. 74% of U.S. millionaires work with a financial advisor - more than double the general population rate. A fiduciary advisor can review your 401(k) for fees, allocation, and alignment with your actual timeline. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors in their area.tc pixel
Manolete Partners PLC Ordinary Shares MANOF
Manolete Partn. Regulatory News
See More Headlines

MANO Stock Analysis - Frequently Asked Questions

Manolete Partners' stock was trading at GBX 58.20 on January 1st, 2026. Since then, MANO stock has decreased by 37.9% and is now trading at GBX 36.15.

Manolete Partners Plc (LON:MANO) issued its quarterly earnings data on Thursday, June, 25th. The company reported $2.50 earnings per share for the quarter. The firm had revenue of $27.88 million for the quarter. Manolete Partners had a trailing twelve-month return on equity of 2.62% and a net margin of 3.92%.

Shares of MANO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Manolete Partners investors own include Advanced Oncotherapy (AVO), IQE (IQE), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR) and Greencore Group (GNC).

Company Calendar

Last Earnings
6/25/2026
Today
9/19/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Professional Services
Sub-Industry
N/A
Current Symbol
LON:MANO
CIK
N/A
Fax
N/A
Employees
29
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 67
Low Price Target
GBX 67
Potential Upside/Downside
+85.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 2.46
Trailing P/E Ratio
14.70
Forward P/E Ratio
8.44
P/E Growth
N/A
Net Income
£40.35 million
Net Margins
3.92%
Pretax Margin
N/A
Return on Equity
2.62%
Return on Assets
2.33%

Debt

Debt-to-Equity Ratio
30.06
Current Ratio
7.43
Quick Ratio
6.25

Sales & Book Value

Annual Sales
£30.61 million
Price / Sales
0.52
Cash Flow
GBX 7.14 per share
Price / Cash Flow
5.07
Book Value
GBX 90.92 per share
Price / Book
0.40

Miscellaneous

Outstanding Shares
43,986,000
Free Float
N/A
Market Cap
£15.90 million
Optionable
Not Optionable
Beta
0.59
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (LON:MANO) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners